Mechanistically, a positive correlation was revealed in this study between CD161 expression and the quantity of CD8+ T cells, which have been demonstrated as promising biomarkers for immunotherapy in various malignant tumors (He et al., 2021). The gene discussed is KLRB1; the disease is cancer.